Jim Simons Liminal Bio Sciences Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.32 - $0.5 $3,165 - $4,946
-9,892 Reduced 20.44%
38,500 $13,000
Q3 2022

Nov 14, 2022
SELL
$0.4 - $0.59 $7,203 - $10,624
-18,008 Reduced 27.12%
48,392 $20,000
Q2 2022

Aug 12, 2022
BUY
$0.44 - $0.97 $13,691 - $30,183
31,117 Added 88.19%
66,400 $34,000
Q1 2022

May 13, 2022
SELL
$0.82 - $1.13 $75,541 - $104,100
-92,124 Reduced 72.31%
35,283 $35,000
Q4 2021

Feb 11, 2022
BUY
$0.92 - $2.2 $117,214 - $280,295
127,407 New
127,407 $139,000

Others Institutions Holding LMNL

# of Institutions
2
Shares Held
234
Call Options Held
0
Put Options Held
0
View Full List

About Liminal BioSciences Inc.

LMNL Quotes by TradingView
  • Ticker LMNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,042,600
  • Description
  • Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...
More about LMNL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email